Investment RecipesIssue #25, 02 December 2020
AtonRâ Partners' research publication, brought to you every 2 weeks, with articles covering the latest developments in our investment themes.
In this issue of Investment Recipes:
China – Macro view
China issued the outline of its 14th Five-Year Plan (FYP) at the end of october. Even if no specific numerical targets have yet been given, it is stated that China is set to “achieve socialist modernization” by 2035 and...
Long march to technological self-sufficiency
China's demography and social contract require massive investments in automation, artificial intelligence and robotics. 2020 is a pivotal year for the country, which first experienced the coronavirus outbreak and first r...
Chasing opportunities in the Chinese MedTech market
China’s manufacturing strategy is moving from the “world’s factory” into an innovation-driven powerhouse offering high-quality medical devices “made in China”. This industrial revolution is reflected in the unprecedented...
China bets on biotech: the tiger’s fangs are coming out
The Chinese biotech market is offering the highest growth rates, a supportive regulatory framework and strong capital inflow. Coupled with structural advantages like a vast patient population and huge amount of data feed...
A New Major Space Power Is Here
Competition with the U.S. and high level of innovation will continue to drive the Chinese space sector. Driven by aspiring plans to colonize the Moon, transform it into a self-sufficient hub for crewed flights, and to la...
China accelerating the green transition
China, as the largest energy consumer and greenhouse gas emitter, has a central role to play in the energy transition. For environmental, economical, and geopolitical reasons, the country understands the need to accelera...
China’s Global Wealth Effect
The top chart, courtesy of Max Roser of Our World in Data, shows how global income distribution has translated to the right, towards a more normal distribution, implying higher income equality.
This report has been produced by the organizational unit responsible for investment research (Research unit) of AtonRâ Partners and sent to you by the company sales representatives.
As an internationally active company, AtonRâ Partners SA may be subject to a number of provisions in drawing up and distributing its investment research documents. These regulations include the Directives on the Independence of Financial Research issued by the Swiss Bankers Association. Although AtonRâ Partners SA believes that the information provided in this document is based on reliable sources, it cannot assume responsibility for the quality, correctness, timeliness or completeness of the information contained in this report.
The information contained in these publications is exclusively intended for a client base consisting of professionals or qualified investors. It is sent to you by way of information and cannot be divulged to a third party without the prior consent of AtonRâ Partners. While all reasonable effort has been made to ensure that the information contained is not untrue or misleading at the time of publication, no representation is made as to its accuracy or completeness and it should not be relied upon as such.
Past performance is not indicative or a guarantee of future results. Investment losses may occur, and investors could lose some or all of their investment. Any indices cited herein are provided only as examples of general market performance and no index is directly comparable to the past or future performance of the Certificate.
It should not be assumed that the Certificate will invest in any specific securities that comprise any index, nor should it be understood to mean that there is a correlation between the Certificate’s returns and any index returns.
Any material provided to you is intended only for discussion purposes and is not intended as an offer or solicitation with respect to the purchase or sale of any security and should not be relied upon by you in evaluating the merits of investing inany securities.